Jen Richie of the Leydig Boulder office will present “Revisiting In re Cellect: Strategy Adjustments and the Narrowing Impact of Allergan USA v. MSN Labs” on August 21, 2024. This webinar will provide an in-depth review of the decision, analyzing the arguments from both sides and its broader implications on patent prosecution strategies. For more information and to register, please visit: https://webinars.ipo.org/
News
